# A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine

> **NCT01053767** · PHASE1 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 95 (actual)

## Conditions studied

- Group B Streptococcus (GBS) Disease

## Interventions

- **BIOLOGICAL:** Group B streptococcus (GBS) vaccine

## Key facts

- **NCT ID:** NCT01053767
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-08
- **Final completion:** 2010-12
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053767, "A Study to Assess the Persistence of Two GBS Antibodies in Women Previously Immunized With a GBS Vaccine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01053767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*